KISS1 and prostate carcinoma: KISS1-GPR54 has been identified as an important intervention target in breast cancer migration (Wang et al., 2017), but its potential as a diagnostic, risk assessment, and therapeutic target for aggressive tumors in prostate cancer remains to be explored.